New kids on the signaling block
Signal relay in eukaryotes enables proper response to chemical or physical signals received by the cell. We now understand how many of the canonical components of signaling pathways exert their functions, including the mode of activation of many kinases and the relationships among receptors, scaffolds and downstream effectors. This understanding has been key to the development of therapeutics targeting signaling components. Yet, from receptors to enzymes such as kinases, phosphatases, ubiquitin ligases and deubiquitinases, the signaling machinery still holds many mysteries.
In this session, we will focus on atypical signaling mechanisms, from the discovery of new catalysis within the kinome superfamily and noncanonical ubiquitination to the role of metals such as copper in signaling. We also discuss the emergence of pseudoenzymes: These allosteric signaling scaffolds are defined by their structural and sequence homology to canonical enzymes such as kinases and phosphatases, but they lack catalytic activity and remain relatively unexplored biologically and as potential drug targets.
We also will discuss how improvements in phosphoproteomics, genetic screens, and affinity and proximity proteomics permit us to globally assess specific aspects of signal transduction and shine new lights on poorly characterized enzymes, scaffolds and substrates.
Keywords: signal transduction, phosphorylation, ubiquitination, post-translational modification, pseudoenzymes, mass spectrometry, CRISPR screens, structural biology, interaction mapping
Who should attend: everyone who likes taking the road less traveled and those interested in good detective stories
Theme song: “Halo” by Beyoncé
This session is powered by ligands and receptors.
Talks
- CRISPR sensors for signaling — Stéphane Angers, University of Toronto
- Tracing copper utilization by kinase signal transduction pathways: Implications for cancer cell processes — Donita Brady, University of Pennsylvania
- How do signaling pseudoenzymes work? — Patrick Eyers, University of Liverpool
- Proximity-dependent sensors for signaling — Anne-Claude Gingras, Mount Sinai Hospital
- Proteome-scale amino-acid resolution footprinting of protein-binding sites in the intrinsically disordered regions — Ylva Ivarsson, Uppsala University
- Structural basis for signaling by the HER3 pseudokinase — Natalia Jura, University of California, San Francisco
- Defining pseudoenzymes in glycosylation pathways — Natarajan Kannan, University of Georgia
- Cell signaling by protein tyrosine phosphatases — Hayley Sharpe, Babraham Institute, Cambridge
- Expanding the kinome — Vinnie Tagliabracci, University of Texas Southwestern Medical Center
- Pseudoenzyme classification — Janet Thornton, European Molecular Biology Laboratory
- A high-dimensional map of phosphorylation-dependent signaling in budding yeast — Judit Villén, University of Washington
- Noncanonical ubiquitination — Satpal Virdee, University of Dundee
Learn more
Check out all ten thematic symposia planned for the 2022 ASBMB annual meeting:
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreFeatured jobs
from the
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Omega-3 fats linked to healthy aging and improved heart metabolism
Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.
RA patient blood reveals joint innerworkings
Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.
Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.
Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.
Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.
Using 'nature’s mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.